Supplementary Figure S11 from KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer Article Swipe

PDF

Sara Santagata , Anna Maria Trotta , Crescenzo D’Alterio , Maria Napolitano , Giuseppina Rea , Marilena Di Napoli , Luigi Portella , Caterina Ieranò , Giuseppe Guardascione , Elisabetta Coppola , Christophe Caux , Bertrand Dubois , Helen Boyle , Joan Carles , Sabrina Rossetti , Rosa Azzaro , Florinda Feroce , Sisto Perdonà , Mario Fordellone , Anna Maria Bello , Daniela Califano , Paolo Chiodini , Sandro Pignata , Stefania Scala ·

YOU? · · 2024 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.27231252

Supplementary Figure S11. HLA class I in primary RCC from REV patients

Related Topics

Concepts

Peripheral blood Physics Molecular biology Medicine Biology Internal medicine

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1078-0432.27231252
PDF: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S11_from_sup_KIR2DL2_DL3_sup_NKs_and_sup_Helios_sup_Tregs_in_Peripheral_Blood_Predict_Nivolumab_Response_in_Patients_with_Metastatic_Renal_Cell_Cancer/27231252/1/files/49797894.pdf
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4403437182

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4403437182

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1078-0432.27231252

Digital Object Identifier
Title: Supplementary Figure S11 from KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2024

Year of publication
Publication date: 2024-10-15

Full publication date if available
Authors: Sara Santagata, Anna Maria Trotta, Crescenzo D’Alterio, Maria Napolitano, Giuseppina Rea, Marilena Di Napoli, Luigi Portella, Caterina Ieranò, Giuseppe Guardascione, Elisabetta Coppola, Christophe Caux, Bertrand Dubois, Helen Boyle, Joan Carles, Sabrina Rossetti, Rosa Azzaro, Florinda Feroce, Sisto Perdonà, Mario Fordellone, Anna Maria Bello, Daniela Califano, Paolo Chiodini, Sandro Pignata, Stefania Scala

List of authors in order
Landing page: https://doi.org/10.1158/1078-0432.27231252

Publisher landing page
PDF URL: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S11_from_sup_KIR2DL2_DL3_sup_NKs_and_sup_Helios_sup_Tregs_in_Peripheral_Blood_Predict_Nivolumab_Response_in_Patients_with_Metastatic_Renal_Cell_Cancer/27231252/1/files/49797894.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S11_from_sup_KIR2DL2_DL3_sup_NKs_and_sup_Helios_sup_Tregs_in_Peripheral_Blood_Predict_Nivolumab_Response_in_Patients_with_Metastatic_Renal_Cell_Cancer/27231252/1/files/49797894.pdf

Direct OA link when available
Concepts: Peripheral blood, Physics, Molecular biology, Medicine, Biology, Internal medicine

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4403437182
doi	https://doi.org/10.1158/1078-0432.27231252
ids.doi	https://doi.org/10.1158/1078-0432.27231252
ids.openalex	https://openalex.org/W4403437182
fwci	0.0
type	preprint
title	Supplementary Figure S11 from <sup>KIR2DL2/DL3+</sup>NKs and <sup>Helios+</sup>Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10158
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9939000010490417
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2730
topics[0].subfield.display_name	Oncology
topics[0].display_name	Cancer Immunotherapy and Biomarkers
topics[1].id	https://openalex.org/T10449
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9685999751091003
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2740
topics[1].subfield.display_name	Pulmonary and Respiratory Medicine
topics[1].display_name	Renal cell carcinoma treatment
topics[2].id	https://openalex.org/T11491
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9300000071525574
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2730
topics[2].subfield.display_name	Oncology
topics[2].display_name	CAR-T cell therapy research
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C3017910909
concepts[0].level	2
concepts[0].score	0.7366698980331421
concepts[0].wikidata	https://www.wikidata.org/wiki/Q618363
concepts[0].display_name	Peripheral blood
concepts[1].id	https://openalex.org/C121332964
concepts[1].level	0
concepts[1].score	0.3924855589866638
concepts[1].wikidata	https://www.wikidata.org/wiki/Q413
concepts[1].display_name	Physics
concepts[2].id	https://openalex.org/C153911025
concepts[2].level	1
concepts[2].score	0.3603839874267578
concepts[2].wikidata	https://www.wikidata.org/wiki/Q7202
concepts[2].display_name	Molecular biology
concepts[3].id	https://openalex.org/C71924100
concepts[3].level	0
concepts[3].score	0.338345468044281
concepts[3].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[3].display_name	Medicine
concepts[4].id	https://openalex.org/C86803240
concepts[4].level	0
concepts[4].score	0.26764100790023804
concepts[4].wikidata	https://www.wikidata.org/wiki/Q420
concepts[4].display_name	Biology
concepts[5].id	https://openalex.org/C126322002
concepts[5].level	1
concepts[5].score	0.25410282611846924
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[5].display_name	Internal medicine
keywords[0].id	https://openalex.org/keywords/peripheral-blood
keywords[0].score	0.7366698980331421
keywords[0].display_name	Peripheral blood
keywords[1].id	https://openalex.org/keywords/physics
keywords[1].score	0.3924855589866638
keywords[1].display_name	Physics
keywords[2].id	https://openalex.org/keywords/molecular-biology
keywords[2].score	0.3603839874267578
keywords[2].display_name	Molecular biology
keywords[3].id	https://openalex.org/keywords/medicine
keywords[3].score	0.338345468044281
keywords[3].display_name	Medicine
keywords[4].id	https://openalex.org/keywords/biology
keywords[4].score	0.26764100790023804
keywords[4].display_name	Biology
keywords[5].id	https://openalex.org/keywords/internal-medicine
keywords[5].score	0.25410282611846924
keywords[5].display_name	Internal medicine
language	en
locations[0].id	doi:10.1158/1078-0432.27231252
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S11_from_sup_KIR2DL2_DL3_sup_NKs_and_sup_Helios_sup_Tregs_in_Peripheral_Blood_Predict_Nivolumab_Response_in_Patients_with_Metastatic_Renal_Cell_Cancer/27231252/1/files/49797894.pdf
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1078-0432.27231252
locations[1].id	pmh:oai:figshare.com:article/27231252
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306400572
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	OPAL (Open@LaTrobe) (La Trobe University)
locations[1].source.host_organization	https://openalex.org/I196829312
locations[1].source.host_organization_name	La Trobe University
locations[1].source.host_organization_lineage	https://openalex.org/I196829312
locations[1].license	cc-by
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Text
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name
locations[1].landing_page_url	https://figshare.com/articles/journal_contribution/Supplementary_Figure_S11_from_sup_KIR2DL2_DL3_sup_NKs_and_sup_Helios_sup_Tregs_in_Peripheral_Blood_Predict_Nivolumab_Response_in_Patients_with_Metastatic_Renal_Cell_Cancer/27231252
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5074752379
authorships[0].author.orcid	https://orcid.org/0000-0001-8680-084X
authorships[0].author.display_name	Sara Santagata
authorships[0].author_position	first
authorships[0].raw_author_name	Sara Santagata
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5062690734
authorships[1].author.orcid	https://orcid.org/0000-0003-4110-2057
authorships[1].author.display_name	Anna Maria Trotta
authorships[1].author_position	middle
authorships[1].raw_author_name	Anna Maria Trotta
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5000562109
authorships[2].author.orcid	https://orcid.org/0000-0003-0275-3367
authorships[2].author.display_name	Crescenzo D’Alterio
authorships[2].author_position	middle
authorships[2].raw_author_name	Crescenzo D’Alterio
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5071834315
authorships[3].author.orcid	https://orcid.org/0000-0002-8996-3297
authorships[3].author.display_name	Maria Napolitano
authorships[3].author_position	middle
authorships[3].raw_author_name	Maria Napolitano
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5086849700
authorships[4].author.orcid	https://orcid.org/0000-0002-5420-395X
authorships[4].author.display_name	Giuseppina Rea
authorships[4].author_position	middle
authorships[4].raw_author_name	Giuseppina Rea
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5008808451
authorships[5].author.orcid	https://orcid.org/0000-0003-4516-7341
authorships[5].author.display_name	Marilena Di Napoli
authorships[5].author_position	middle
authorships[5].raw_author_name	Marilena Di Napoli
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5043459299
authorships[6].author.orcid	https://orcid.org/0000-0002-8679-3309
authorships[6].author.display_name	Luigi Portella
authorships[6].author_position	middle
authorships[6].raw_author_name	Luigi Portella
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5006137154
authorships[7].author.orcid	https://orcid.org/0000-0003-3138-1873
authorships[7].author.display_name	Caterina Ieranò
authorships[7].author_position	middle
authorships[7].raw_author_name	Caterina Ieranò
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5088633559
authorships[8].author.orcid	https://orcid.org/0000-0003-4272-7948
authorships[8].author.display_name	Giuseppe Guardascione
authorships[8].author_position	middle
authorships[8].raw_author_name	Giuseppe Guardascione
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5001029550
authorships[9].author.orcid	https://orcid.org/0000-0001-7765-8909
authorships[9].author.display_name	Elisabetta Coppola
authorships[9].author_position	middle
authorships[9].raw_author_name	Elisabetta Coppola
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5025970784
authorships[10].author.orcid	https://orcid.org/0000-0003-2438-833X
authorships[10].author.display_name	Christophe Caux
authorships[10].author_position	middle
authorships[10].raw_author_name	Christophe Caux
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5032420776
authorships[11].author.orcid	https://orcid.org/0000-0002-7859-4975
authorships[11].author.display_name	Bertrand Dubois
authorships[11].author_position	middle
authorships[11].raw_author_name	Bertrand Dubois
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5036852227
authorships[12].author.orcid	https://orcid.org/0000-0002-8201-948X
authorships[12].author.display_name	Helen Boyle
authorships[12].author_position	middle
authorships[12].raw_author_name	Helen J. Boyle
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5001994148
authorships[13].author.orcid	https://orcid.org/0000-0002-9983-5934
authorships[13].author.display_name	Joan Carles
authorships[13].author_position	middle
authorships[13].raw_author_name	Joan Carles
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5047133719
authorships[14].author.orcid	https://orcid.org/0000-0002-9337-5885
authorships[14].author.display_name	Sabrina Rossetti
authorships[14].author_position	middle
authorships[14].raw_author_name	Sabrina Rossetti
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5106377788
authorships[15].author.orcid	https://orcid.org/0000-0003-4283-9800
authorships[15].author.display_name	Rosa Azzaro
authorships[15].author_position	middle
authorships[15].raw_author_name	Rosa Azzaro
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5087184004
authorships[16].author.orcid	https://orcid.org/0000-0003-0942-7046
authorships[16].author.display_name	Florinda Feroce
authorships[16].author_position	middle
authorships[16].raw_author_name	Florinda Feroce
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5024587083
authorships[17].author.orcid	https://orcid.org/0000-0001-8683-4644
authorships[17].author.display_name	Sisto Perdonà
authorships[17].author_position	middle
authorships[17].raw_author_name	Sisto Perdonà
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5050908003
authorships[18].author.orcid	https://orcid.org/0000-0003-0790-892X
authorships[18].author.display_name	Mario Fordellone
authorships[18].author_position	middle
authorships[18].raw_author_name	Mario Fordellone
authorships[18].is_corresponding	False
authorships[19].author.id	https://openalex.org/A5000156274
authorships[19].author.orcid	https://orcid.org/0000-0001-6975-3340
authorships[19].author.display_name	Anna Maria Bello
authorships[19].author_position	middle
authorships[19].raw_author_name	Anna Maria Bello
authorships[19].is_corresponding	False
authorships[20].author.id	https://openalex.org/A5040899290
authorships[20].author.orcid	https://orcid.org/0000-0001-6945-3209
authorships[20].author.display_name	Daniela Califano
authorships[20].author_position	middle
authorships[20].raw_author_name	Daniela Califano
authorships[20].is_corresponding	False
authorships[21].author.id	https://openalex.org/A5048229494
authorships[21].author.orcid	https://orcid.org/0000-0003-0139-2264
authorships[21].author.display_name	Paolo Chiodini
authorships[21].author_position	middle
authorships[21].raw_author_name	Paolo Chiodini
authorships[21].is_corresponding	False
authorships[22].author.id	https://openalex.org/A5083659627
authorships[22].author.orcid	https://orcid.org/0000-0002-8836-2633
authorships[22].author.display_name	Sandro Pignata
authorships[22].author_position	middle
authorships[22].raw_author_name	Sandro Pignata
authorships[22].is_corresponding	False
authorships[23].author.id	https://openalex.org/A5028542645
authorships[23].author.orcid	https://orcid.org/0000-0001-9524-2616
authorships[23].author.display_name	Stefania Scala
authorships[23].author_position	last
authorships[23].raw_author_name	Stefania Scala
authorships[23].is_corresponding	False
has_content.pdf	True
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S11_from_sup_KIR2DL2_DL3_sup_NKs_and_sup_Helios_sup_Tregs_in_Peripheral_Blood_Predict_Nivolumab_Response_in_Patients_with_Metastatic_Renal_Cell_Cancer/27231252/1/files/49797894.pdf
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Figure S11 from <sup>KIR2DL2/DL3+</sup>NKs and <sup>Helios+</sup>Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10158
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9939000010490417
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2730
primary_topic.subfield.display_name	Oncology
primary_topic.display_name	Cancer Immunotherapy and Biomarkers
related_works	https://openalex.org/W4391375266, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W2935759653, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1158/1078-0432.27231252
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S11_from_sup_KIR2DL2_DL3_sup_NKs_and_sup_Helios_sup_Tregs_in_Peripheral_Blood_Predict_Nivolumab_Response_in_Patients_with_Metastatic_Renal_Cell_Cancer/27231252/1/files/49797894.pdf
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1078-0432.27231252
primary_location.id	doi:10.1158/1078-0432.27231252
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S11_from_sup_KIR2DL2_DL3_sup_NKs_and_sup_Helios_sup_Tregs_in_Peripheral_Blood_Predict_Nivolumab_Response_in_Patients_with_Metastatic_Renal_Cell_Cancer/27231252/1/files/49797894.pdf
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1078-0432.27231252
publication_date	2024-10-15
publication_year	2024
referenced_works_count	0
abstract_inverted_index.I	5
abstract_inverted_index.in	6
abstract_inverted_index.HLA	3
abstract_inverted_index.RCC	8
abstract_inverted_index.REV	10
abstract_inverted_index.S11.	2
abstract_inverted_index.from	9
abstract_inverted_index.class	4
abstract_inverted_index.Figure	1
abstract_inverted_index.primary	7
abstract_inverted_index.patients</p>	11
abstract_inverted_index.<p>Supplementary	0
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	24
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.5799999833106995
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.34968646
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False

Supplementary Figure S11 from <sup>KIR2DL2/DL3+</sup>NKs and <sup>Helios+</sup>Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer Article Swipe

Related Topics

Raw OpenAlex JSON

Full payload